Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
PuraPharm Corp. Ltd. ( (HK:1498) ) just unveiled an announcement.
PuraPharm Corporation Limited has announced an extraordinary general meeting to discuss and approve two major agreements. The first is a Patent Licence Agreement which involves granting an exclusive non-transferable licence of certain intellectual property to PuraPharm, with a one-off non-refundable licence fee of HK$40,200,000. The second is a Subscription Agreement for the issuance of 46,512,000 Subscription Shares at a price of HK$0.43 per share. These agreements are expected to impact the company’s operations and financial positioning.
The most recent analyst rating on (HK:1498) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on PuraPharm Corp. Ltd. stock, see the HK:1498 Stock Forecast page.
More about PuraPharm Corp. Ltd.
Average Trading Volume: 227,358
Technical Sentiment Signal: Sell
Current Market Cap: HK$171.8M
For detailed information about 1498 stock, go to TipRanks’ Stock Analysis page.